| PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression CL Day, DE Kaufmann, P Kiepiela, JA Brown, ES Moodley, S Reddy, ... Nature 443 (7109), 350-354, 2006 | 3345 | 2006 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 838 | 2021 |
| Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction DE Kaufmann, DG Kavanagh, F Pereyra, JJ Zaunders, EW Mackey, ... Nature immunology 8 (11), 1246-1254, 2007 | 723 | 2007 |
| Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy F Pereyra, MM Addo, DE Kaufmann, Y Liu, T Miura, A Rathod, B Baker, ... The Journal of infectious diseases 197 (4), 563-571, 2008 | 684 | 2008 |
| AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study B Ledergerber, M Egger, V Erard, R Weber, B Hirschel, H Furrer, ... Jama 282 (23), 2220-2226, 1999 | 638 | 1999 |
| Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF M Quigley, F Pereyra, B Nilsson, F Porichis, C Fonseca, Q Eichbaum, ... Nature medicine 16 (10), 1147-1151, 2010 | 618 | 2010 |
| A blueprint for HIV vaccine discovery DR Burton, R Ahmed, DH Barouch, ST Butera, S Crotty, A Godzik, ... Cell host & microbe 12 (4), 396-407, 2012 | 465 | 2012 |
| Loss of HIV-1–specific CD8+ T Cell Proliferation after Acute HIV-1 Infection and Restoration by Vaccine-induced HIV-1–specific CD4+ T Cells M Lichterfeld, DE Kaufmann, XG Yu, SK Mui, MM Addo, MN Johnston, ... The Journal of experimental medicine 200 (6), 701-712, 2004 | 446 | 2004 |
| Selective Escape from CD8+ T-Cell Responses Represents a Major Driving Force of Human Immunodeficiency Virus Type 1 (HIV-1) Sequence Diversity and … TM Allen, M Altfeld, SC Geer, ET Kalife, C Moore, KM O'sullivan, ... Journal of virology 79 (21), 13239-13249, 2005 | 401 | 2005 |
| CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART) D Kaufmann, G Pantaleo, P Sudre, A Telenti The Lancet 351 (9104), 723-724, 1998 | 390 | 1998 |
| CXCL13 is a plasma biomarker of germinal center activity C Havenar-Daughton, M Lindqvist, A Heit, JE Wu, SM Reiss, K Kendric, ... Proceedings of the National Academy of Sciences 113 (10), 2702-2707, 2016 | 347 | 2016 |
| IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells MA Brockman, DS Kwon, DP Tighe, DF Pavlik, PC Rosato, J Sela, ... Blood, The Journal of the American Society of Hematology 114 (2), 346-356, 2009 | 344 | 2009 |
| Comparative analysis of activation induced marker (AIM) assays for sensitive identification of antigen-specific CD4 T cells S Reiss, AE Baxter, KM Cirelli, JM Dan, A Morou, A Daigneault, ... PloS one 12 (10), e0186998, 2017 | 309 | 2017 |
| Whole-genome sequencing reveals host factors underlying critical COVID-19 A Kousathanas, E Pairo-Castineira, K Rawlik, A Stuckey, CA Odhams, ... Nature 607 (7917), 97-103, 2022 | 305 | 2022 |
| PD-1 and CTLA-4 inhibitory cosignaling pathways in HIV infection and the potential for therapeutic intervention DE Kaufmann, BD Walker The Journal of Immunology 182 (10), 5891-5897, 2009 | 295 | 2009 |
| Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity M Veillette, A Désormeaux, H Medjahed, NE Gharsallah, M Coutu, ... Journal of virology 88 (5), 2633-2644, 2014 | 292 | 2014 |
| TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection H Chen, ZM Ndhlovu, D Liu, LC Porter, JW Fang, S Darko, MA Brockman, ... Nature immunology 13 (7), 691-700, 2012 | 279 | 2012 |
| Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial P Bégin, J Callum, E Jamula, R Cook, NM Heddle, A Tinmouth, MP Zeller, ... Nature medicine 27 (11), 2012-2024, 2021 | 272 | 2021 |
| Limited durability of viral control following treated acute HIV infection DE Kaufmann, M Lichterfeld, M Altfeld, MM Addo, MN Johnston, PK Lee, ... PLoS medicine 1 (2), e36, 2004 | 254 | 2004 |
| A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity S Zhou, G Butler-Laporte, T Nakanishi, DR Morrison, J Afilalo, M Afilalo, ... Nature medicine 27 (4), 659-667, 2021 | 243 | 2021 |
